Ecstasy induces reactive oxygen species, kidney water absorption and rhabdomyolysis in normal rats. Effect of N-acetylcysteine and Allopurinol in oxidative stress and muscle fiber damage

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author BRAGANCA, Ana C. de FMUSP-HC
MOREAU, Regina L. M.
BRITO, Thales de FMUSP-HC
SHIMIZU, Maria H. M. FMUSP-HC
CANALE, Daniele FMUSP-HC
JESUS, Denise A. de FMUSP-HC
SILVA, Ana M. G. FMUSP-HC
GOIS, Pedro H. FMUSP-HC
SEGURO, Antonio C. FMUSP-HC
MAGALDI, Antonio J. FMUSP-HC
dc.date.issued 2017
dc.identifier.citation PLOS ONE, v.12, n.7, article ID e0179199, 12p, 2017
dc.identifier.issn 1932-6203
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/21427
dc.description.abstract Background Ecstasy (Ec) use produces hyperthermia, excessive sweating, intense thirst, an inappropriate antidiuretic hormone secretion (SIADH) and a multisystemic toxicity due to oxidative stress (OS). Intense thirst induces high intake of pure water, which associated with SIADH, usually develops into acute hyponatremia (Hn). As Hn is induced rapidly, experiments to check if Ec acted directly on the Inner Medullary Collecting Ducts (IMCD) of rats were conducted. Rhabdomyolysis and OS were also studied because Ec is known to induce Reactive Oxygen Species (ROS) and tissue damage. To decrease OS, the antioxidant inhibitors N-acetylcysteine (NAC) and Allopurinol (Allo) were used. Methods Rats were maintained on a lithium (Li) diet to block the Vasopressin action before Ec innoculation. AQP2 (Aquaporin 2), ENaC (Epitheliun Sodium Channel) and NKCC2 (Sodium, Potassium, 2 Chloride) expression were determined by Western Blot in isolated IMCDs. The TBARS (thiobarbituric acid reactive substances) and GSH (reduced form of Glutathione) were determined in the Ec group (6 rats injected with Ec-10mg/kg), in Ec+NAC groups (NAC 100mg/Kg/bw i.p.) and in Allo+Ec groups (Allo 50mg/Kg/i.p.). Results Enhanced AQP2 expression revealed that Ec increased water transporter expression, decreased by Li diet, but the expression of the tubular transporters did not change. The Ec, Ec+NAC and Allo+Ec results showed that Ec increased TBARS and decreased GSH, showing evidence of ROS occurrence, which was protected by NAC and Allo. Rhabdomyolysis was only protected by Allo. Conclusion Results showed that Ec induced an increase in AQP2 expression, evidencing another mechanism that might contribute to cause rapid hyponatremia. In addition, they showed that NAC and Allo protected against OS, but only Allo decreased rhabdomyolysis and hyperthermia.
dc.language.iso eng
dc.publisher PUBLIC LIBRARY SCIENCE
dc.relation.ispartof Plos One
dc.rights openAccess
dc.subject.other mdma ecstasy; in-vitro; 3,4-methylenedioxymethamphetamine mdma; abuse; hyponatremia; temperature; ingestion; vasopressin; dysfunction; metabolism
dc.title Ecstasy induces reactive oxygen species, kidney water absorption and rhabdomyolysis in normal rats. Effect of N-acetylcysteine and Allopurinol in oxidative stress and muscle fiber damage
dc.type article
dc.rights.holder Copyright PUBLIC LIBRARY SCIENCE
dc.description.group LIM/12
dc.description.group LIM/06
dc.identifier.doi 10.1371/journal.pone.0179199
dc.identifier.pmid 28678861
dc.type.category original article
dc.type.version publishedVersion
hcfmusp.author BRAGANCA, Ana C. de:HC:LIM/12
hcfmusp.author BRITO, Thales de:FM:MPT
hcfmusp.author SHIMIZU, Maria H. M.:FM:MCM
hcfmusp.author CANALE, Daniele:FM:MCM
hcfmusp.author JESUS, Denise A. de:FM:MCM
hcfmusp.author SILVA, Ana M. G.:HC:LIM/06
hcfmusp.author GOIS, Pedro H.:HC:LIM/12
hcfmusp.author SEGURO, Antonio C.:HC:ICHC
hcfmusp.author MAGALDI, Antonio J.:HC:ICHC
hcfmusp.author.external · MOREAU, Regina L. M.:Univ Sao Paulo, Dept Clin & Toxicol Anal, Sch Pharmaceut Sci, Sao Paulo, SP, Brazil
hcfmusp.origem.id WOS:000405272200008
hcfmusp.origem.id 2-s2.0-85022004305
hcfmusp.publisher.city SAN FRANCISCO
hcfmusp.publisher.country USA
hcfmusp.relation.reference · Asl SS, 2015, METAB BRAIN DIS, V30, P171, DOI 10.1007/s11011-014-9598-0
· Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327
· Budisavljevic MN, 2003, AM J MED SCI, V326, P89, DOI 10.1097/00000441-200308000-00006
· BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
· Butler R, 2000, HYPERTENSION, V35, P746
· Campbell GA, 2008, CLIN J AM SOC NEPHRO, V3, P1852, DOI 10.2215/CJN.02080508
· Carvalho M, 2002, ARCH TOXICOL, V76, P581, DOI 10.1007/s00204-002-0381-3
· Carvalho M, 2012, ARCH TOXICOL, V86, P1167, DOI 10.1007/s00204-012-0815-5
· da Silva DD, 2014, J APPL TOXICOL, V34, P637, DOI 10.1002/jat.2889
· DIAZ PT, 1994, J APPL PHYSIOL, V77, P2434
· Eede HV, 2009, J EMERGENCY MED, V42, P655
· El-Bassossy HM, 2015, J TRANSL MED, V3, P82
· Fiaschi AI, 2010, CURR PHARM BIOTECHNO, V11, P444
· Ghatol A, 2012, J EMERGENCY MED, V42, P137
· Gois PHF, 2016, FREE RADICAL BIO MED, V101, P176, DOI 10.1016/j.freeradbiomed.2016.10.012
· Gomez-Cabrera MC, 2003, JAMA-J AM MED ASSOC, V289, P2503, DOI 10.1001/jama.289.19.2503-b
· Halpern P, 2011, HUM EXP TOXICOL, V30, P259, DOI 10.1177/0960327110370984
· Henry JA, 1998, LANCET, V351, P1784, DOI 10.1016/S0140-6736(05)78744-4
· Hoo GWS, 2012, J INTENSIVE CARE MED, V28, P259
· Kaandorp JJ, 2014, ARCH DIS CHILD-FETAL, V99, pF144, DOI 10.1136/archdischild-2013-304876
· Kalantar-Zadeh K, 2006, NAT CLIN PRACT NEPHR, V2, P283, DOI 10.1038/ncpneph0167
· Katz A, 2014, PFLUG ARCH EUR J PHY, V466, P577, DOI 10.1007/s00424-013-1331-z
· Keltz Eran, 2013, Muscles Ligaments Tendons J, V3, P303
· Kunsdorf-Wnuk Anna, 2005, Pol Merkur Lekarski, V18, P436
· Kwon C, 2003, PEDIATR NEPHROL, V18, P820, DOI 10.1007/s00467-003-1164-7
· Lin PY, 2011, PEDIATR CRIT CARE ME, V12, pE424, DOI 10.1097/PCC.0b013e3182192c8d
· Lourenco TC, 2013, J PHARMACEUT BIOMED, V73, P13, DOI 10.1016/j.jpba.2012.01.025
· Matthai SM, 1996, BRIT MED J, V312, P1359
· OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
· Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6
· Parrott AC, 2012, DRUG ALCOHOL DEPEN, V121, P1, DOI 10.1016/j.drugalcdep.2011.08.012
· Paula VF, 2009, NEUROIMMUNOMODULAT, V16, P191
· Pendergraft WF, 2014, CLIN J AM SOC NEPHRO, V9, P1996, DOI 10.2215/CJN.00360114
· Ramaley C, 2014, J ANAL TOXICOL, V38, P249, DOI 10.1093/jat/bku023
· SCREATON GR, 1992, LANCET, V339, P677, DOI 10.1016/0140-6736(92)90834-P
· SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4
· Song BJ, 2010, CURR PHARM BIOTECHNO, V11, P434
· Sprague JE, 2005, CRIT CARE MED, V33, P1311, DOI 10.1097/01.CCM.0000165969.29002
· Torres A. P, 2015, OCHSNER J, V15, P58
· Traub SJ, 2002, J URBAN HEALTH, V79, P549, DOI 10.1093/jurban/79.4.549
· Vogt BL, 2007, BIOCHEM PHARMACOL, V73, P1613, DOI 10.1016/j.bcp.2007.01.033
· Wolff K, 2006, J PSYCHOPHARMACOL, V20, P400, DOI 10.1177/0269881106061514
dc.description.index MEDLINE
hcfmusp.citation.scopus 2
hcfmusp.citation.wos 4
hcfmusp.affiliation.country Brasil


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics